The past 10 years have been eventful for pharma. The domestic market has grown to Rs 1.1 trillion from Rs 363 billion in 2008. There have been 97,240 brand launches, and exports, led by the US market, almost doubled from $8.7 billion in 2008-09 to $16.88 billion in 2016-17.
It has also been a decade of major mergers and acquisitions, the most noteworthy one perhaps being the Sun Pharma-Ranbaxy deal and the epic hostile acquisition of Israel’s Taro by Sun Pharma.
An industry veteran who was at the helm of a leading pharmaceutical company in India says these are two